Human Reproduction, Vol. 14, No. 3, 716-721,
March 1999
© 1999 European Society of Human Reproduction and Embryology
Changes in vascular basement membrane in the endometrium of Norplant users
1 Department of Obstetrics and Gynaecology, Imperial College School of Medicine at St. Mary's, Norfolk Place, London W2 1PG, 2 Department of Obstetrics and Gynaecology and 3 Department of Anatomical Pathology, University of Sydney, NSW 2006, Australia
Progestogen-only contraception is almost invariably associated with changes in menstrual bleeding patterns. Changes in the endometrial vasculature, and in particular an increase in vascular fragility, may contribute to this bleeding. In this study, endometrial vascular density and endothelial cell basement membrane components were examined using immunohistochemistry before and after insertion of Norplant®. Endometrial vascular density was increased from a mean (± SEM) of 189.6 ± 7.0 vessels/mm2 during the control cycle to 253.9 ± 80.7 vessels/mm2 at 2–13 weeks of Norplant exposure, and to 212.7 ± 12.9 vessels/mm2 at 14–42 weeks. During the control cycle, a mean of 161.4 ± 4.5 vessels/mm2 stained for collagen IV (85% of all vessels), while at 2–13 weeks, 144.5 ± 13.0 vessels/mm2 stained for collagen IV (57% of all vessels) (t ratio = 2.08, P = 0.0057). By 14–42 weeks, 71% of vessels (151.0 ± 9.8) vessels/mm2 were surrounded by collagen IV. This was not significantly different from control values (t ratio = 2.03). Endometrial vascular laminin was also reduced following Norplant insertion, from a mean of 176.0 ± 4.2 vessels/mm2 in the control cycle (93% of vessels), to 156.3 ± 6.7 vessels/mm2 at 2–13 weeks of exposure (57% of vessels) (t ratio = 2.08, P = 0.01). By 14–42 weeks of exposure to Norplant, 162.5 ± 9 vessels/mm2 (76%) stained for laminin. This was not significantly different from control values (t ratio = 2.04). Endometrial vascular heparan sulphate proteoglycan (HSPG) was reduced from 58.6 ± 3.0 vessels/mm2 during the control cycle (31% of vessels) to 43.6 ± 5.6 vessels/mm2 (only 17% of vessels) at 2–13 weeks (t ratio = 2.08, P = 0.025). At 14–42 weeks, only 19% of vessels stained for HSPG (41.3 ± 5.8 vessels/mm2; t ratio = 2.04, P = 0.009).
Key words: basement membrane/collagen IV/endometrium/endothelial/laminin/Norplant/proteoglycan
4 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Huang, N. Song, Y. Ding, S. Yuan, X. Li, H. Cai, H. Shi, and Y. Luo Pulmonary Vascular Destabilization in the Premetastatic Phase Facilitates Lung Metastasis Cancer Res., October 1, 2009; 69(19): 7529 - 7537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Labied, C. Galant, M. Nisolle, S. Ravet, C. Munaut, E. Marbaix, J.-M. Foidart, and F. Frankenne Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time Hum. Reprod., January 1, 2009; 24(1): 113 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Stephanie, S. Labied, S. Blacher, F. Frankenne, C. Munaut, V. Fridman, A. Beliard, J.-M. Foidart, and M. Nisolle Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time Hum. Reprod., December 1, 2007; 22(12): 3084 - 3091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.A. Roopa, A. Loganath, and K. Singh The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium Hum. Reprod., September 1, 2003; 18(9): 1809 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hickey, G. Pillai, J.M. Higham, M. Sullivan, D. Horncastle, D. Doherty, and G. Stamp Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding Hum. Reprod., May 1, 2003; 18(5): 1100 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.B. Laoag-Fernandez, T. Maruo, P. Pakarinen, I.M. Spitz, and E. Johansson Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis Hum. Reprod., April 1, 2003; 18(4): 694 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hickey and I.S. Fraser Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding Hum. Reprod., September 1, 2002; 17(9): 2428 - 2434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.J. Vincent, J. Zhang, A. Ostor, P.A.W. Rogers, B. Affandi, G. Kovacs, and L.A. Salamonsen Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? Hum. Reprod., May 1, 2002; 17(5): 1189 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The ESHRE Capri Workshop Group Ovarian and endometrial function during hormonal contraception Hum. Reprod., July 1, 2001; 16(7): 1527 - 1535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wahab, J. Thompson, and F. Al-Azzawi Effect of different cyclical sequential progestins on endometrial vascularity in postmenopausal women compared with the natural cycle: a morphometric analysis Hum. Reprod., October 1, 2000; 15(10): 2075 - 2081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cheng, H. Zhu, A. Wang, F. Ren, J. Chen, and A. Glasier Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel Hum. Reprod., September 1, 2000; 15(9): 1969 - 1972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hickey, D. Dwarte, and I.S. Fraser Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding Hum. Reprod., July 1, 2000; 15(7): 1509 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Macpherson, D. F. Archer, S. Leslie, D.S. Charnock-Jones, W.K. Makkink, and S. K. Smith The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium Hum. Reprod., December 1, 1999; 14(12): 3080 - 3087. [Abstract] [Full Text] [PDF]
|
|